# Klaviyo timeline

entity: /record/klaviyo.md  
id: ent_klaviyo  


## undated

- undated | state_of_incorporation | DE | valid | [clm_06CFE9017001](/claim/clm_06CFE9017001.md)
- undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_08CA65BEA7B8](/claim/clm_08CA65BEA7B8.md)
- undated | registrant_name | Klaviyo, Inc. | valid | [clm_1D78E5622E6A](/claim/clm_1D78E5622E6A.md)
- undated | cik | 0001835830 | valid | [clm_37F4919DB9FC](/claim/clm_37F4919DB9FC.md)
- undated | ticker | KVYO | valid | [clm_4C96423E7E7F](/claim/clm_4C96423E7E7F.md)
- undated | listed_on | NYSE | valid | [clm_A6ED35AFC154](/claim/clm_A6ED35AFC154.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_AB90696FF891](/claim/clm_AB90696FF891.md)
- undated | produces | customer data platform | unverified | [clm_067857570272](/claim/clm_067857570272.md)
- undated | website | https://www.klaviyo.com/fr/ | unverified | [clm_140EE0A1F89B](/claim/clm_140EE0A1F89B.md)
- undated | headquarters | Boston | unverified | [clm_20E8E9B37B78](/claim/clm_20E8E9B37B78.md)
- undated | produces | mobile marketing | valid | [clm_363784153C7F](/claim/clm_363784153C7F.md)
- undated | website | https://www.klaviyo.com/es/ | unverified | [clm_778959047954](/claim/clm_778959047954.md)
- undated | industry | marketing software industry | valid | [clm_7A4A32D702A3](/claim/clm_7A4A32D702A3.md)
- undated | produces | email marketing | unverified | [clm_8DE61FA619AC](/claim/clm_8DE61FA619AC.md)
- undated | website | https://www.klaviyo.com/de/ | unverified | [clm_92B48381E763](/claim/clm_92B48381E763.md)
- undated | country | United States | unverified | [clm_96F31AB41937](/claim/clm_96F31AB41937.md)
- undated | website | https://www.klaviyo.com/it/ | unverified | [clm_BB0DC14F9A25](/claim/clm_BB0DC14F9A25.md)
- undated | website | https://www.klaviyo.com | unverified | [clm_C62B6A1F94C3](/claim/clm_C62B6A1F94C3.md)
- undated | website | https://www.klaviyo.com/uk/ | unverified | [clm_CBA5814838C9](/claim/clm_CBA5814838C9.md)
- undated | produces | customer relationship management software | unverified | [clm_D62315C4BFAA](/claim/clm_D62315C4BFAA.md)
- undated | industry | information technology | unverified | [clm_F6F8B297D847](/claim/clm_F6F8B297D847.md)

## 2012

- 2012-03-01 | x_username | klaviyo | unverified | [clm_C0A0FC2866B7](/claim/clm_C0A0FC2866B7.md)

## 2020

- 2020-12-31 to 2021-12-31 | total_equity | -759,737,000 United States dollar | superseded | [clm_801166865F44](/claim/clm_801166865F44.md)

## 2021

- 2021-12-31 to 2022-12-31 | research_and_development | 65,599,000 United States dollar | superseded | [clm_1FEF0C270C47](/claim/clm_1FEF0C270C47.md)
- 2021-12-31 to 2022-12-31 | operating_income | -79,233,000 United States dollar | superseded | [clm_9366B773A969](/claim/clm_9366B773A969.md)
- 2021-12-31 to 2022-06-30 | total_equity | -2,236,064,000 United States dollar | superseded | [clm_9B4CCA0999B6](/claim/clm_9B4CCA0999B6.md)
- 2021-12-31 to 2022-12-31 | net_income | -79,393,000 United States dollar | superseded | [clm_C56418A50E57](/claim/clm_C56418A50E57.md)
- 2021-12-31 to 2022-12-31 | revenue | 290,640,000 United States dollar | superseded | [clm_E33754B09FF2](/claim/clm_E33754B09FF2.md)

## 2022

- 2022-06-30 to 2022-09-30 | total_equity | -1,223,504,000 United States dollar | superseded | [clm_EC65091E9AF5](/claim/clm_EC65091E9AF5.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | -23,873,000 United States dollar | superseded | [clm_67E7076B9E2B](/claim/clm_67E7076B9E2B.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 119,168,000 United States dollar | superseded | [clm_98662F30B329](/claim/clm_98662F30B329.md)
- 2022-09-30 to 2022-12-31 | total_equity | -1,054,617,000 United States dollar | superseded | [clm_9D08342317C0](/claim/clm_9D08342317C0.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 30,090,000 United States dollar | superseded | [clm_B0E1CDBAF2FC](/claim/clm_B0E1CDBAF2FC.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | -25,663,000 United States dollar | superseded | [clm_BF323A7183E3](/claim/clm_BF323A7183E3.md)
- 2022-12-31 to 2023-12-31 | operating_income | -55,036,000 United States dollar | superseded | [clm_0472D733739F](/claim/clm_0472D733739F.md)
- 2022-12-31 to 2023-03-31 | total_equity | -1,036,183,000 United States dollar | superseded | [clm_24CD2B034E38](/claim/clm_24CD2B034E38.md)
- 2022-12-31 to 2023-09-30 | total_assets | 629,079,000 United States dollar | superseded | [clm_6695A3C5211C](/claim/clm_6695A3C5211C.md)
- 2022-12-31 to 2023-12-31 | revenue | 472,748,000 United States dollar | superseded | [clm_7079AF81BE2B](/claim/clm_7079AF81BE2B.md)
- 2022-12-31 to 2023-12-31 | net_income | -49,193,000 United States dollar | superseded | [clm_77CF96CF30C6](/claim/clm_77CF96CF30C6.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 104,077,000 United States dollar | superseded | [clm_DC9CB7F6F589](/claim/clm_DC9CB7F6F589.md)
- 2022-12-31 to 2023-09-30 | cash_and_equivalents | 385,820,000 United States dollar | superseded | [clm_ECC0277F9568](/claim/clm_ECC0277F9568.md)

## 2023

- 2023-03-31 to 2023-06-30 | quarterly_net_income | 4,278,000 United States dollar | superseded | [clm_2D6B53E481A0](/claim/clm_2D6B53E481A0.md)
- 2023-03-31 to 2023-06-30 | total_equity | -1,051,828,000 United States dollar | superseded | [clm_45788A7B1DA0](/claim/clm_45788A7B1DA0.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | 878,000 United States dollar | superseded | [clm_86840E91CDA8](/claim/clm_86840E91CDA8.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 156,088,000 United States dollar | superseded | [clm_877CDFCFE1BA](/claim/clm_877CDFCFE1BA.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 35,032,000 United States dollar | superseded | [clm_A2EEC1888F57](/claim/clm_A2EEC1888F57.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | 7,032,000 United States dollar | superseded | [clm_1D6FC2149C76](/claim/clm_1D6FC2149C76.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 33,055,000 United States dollar | superseded | [clm_7B8261612CCF](/claim/clm_7B8261612CCF.md)
- 2023-06-30 to 2023-09-30 | total_equity | -1,082,474,000 United States dollar | superseded | [clm_82D33AAC167F](/claim/clm_82D33AAC167F.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 10,887,000 United States dollar | superseded | [clm_A110DA9422AA](/claim/clm_A110DA9422AA.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 164,586,000 United States dollar | superseded | [clm_AC643B32567A](/claim/clm_AC643B32567A.md)
- 2023-09-20 | listed_on | New York Stock Exchange | unverified | [clm_86422C0C791A](/claim/clm_86422C0C791A.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 723,415,000 United States dollar | superseded | [clm_1BCB2B7A4030](/claim/clm_1BCB2B7A4030.md)
- 2023-09-30 to 2023-12-31 | total_assets | 1,071,424,000 United States dollar | superseded | [clm_22B124828F47](/claim/clm_22B124828F47.md)
- 2023-09-30 to 2023-12-31 | total_equity | 905,344,000 United States dollar | superseded | [clm_6F4C633C8352](/claim/clm_6F4C633C8352.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 141,455,000 United States dollar | superseded | [clm_70B3326F7673](/claim/clm_70B3326F7673.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -302,203,000 United States dollar | superseded | [clm_AF4B64DACA9B](/claim/clm_AF4B64DACA9B.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 175,807,000 United States dollar | superseded | [clm_B9401340C20F](/claim/clm_B9401340C20F.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | -297,104,000 United States dollar | superseded | [clm_CA99B7D7D439](/claim/clm_CA99B7D7D439.md)
- 2023-12-31 to 2024-12-31 | operating_income | -330,622,000 United States dollar | superseded | [clm_33F5A234C6B9](/claim/clm_33F5A234C6B9.md)
- 2023-12-31 to 2024-12-31 | revenue | 698,099,000 United States dollar | superseded | [clm_5AB292CBAB1A](/claim/clm_5AB292CBAB1A.md)
- 2023-12-31 to 2024-12-31 | net_income | -308,233,000 United States dollar | superseded | [clm_67BD84BAB336](/claim/clm_67BD84BAB336.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 262,177,000 United States dollar | superseded | [clm_8A2DF2492135](/claim/clm_8A2DF2492135.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 738,562,000 United States dollar | superseded | [clm_C7776EB2A223](/claim/clm_C7776EB2A223.md)
- 2023-12-31 to 2024-03-31 | total_assets | 1,089,050,000 United States dollar | superseded | [clm_D93CF492FE48](/claim/clm_D93CF492FE48.md)
- 2023-12-31 to 2024-03-31 | total_equity | 914,777,000 United States dollar | superseded | [clm_F80A1B8F555E](/claim/clm_F80A1B8F555E.md)

## 2024

- 2024-03-31 to 2024-06-30 | quarterly_net_income | -12,882,000 United States dollar | superseded | [clm_1269CE18C291](/claim/clm_1269CE18C291.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 209,993,000 United States dollar | superseded | [clm_16F498750D10](/claim/clm_16F498750D10.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | -22,092,000 United States dollar | superseded | [clm_54763C2BB7A2](/claim/clm_54763C2BB7A2.md)
- 2024-03-31 to 2024-06-30 | total_equity | 937,452,000 United States dollar | superseded | [clm_9D169B964ED3](/claim/clm_9D169B964ED3.md)
- 2024-03-31 to 2024-06-30 | total_assets | 1,108,396,000 United States dollar | superseded | [clm_D0C4B4DAAEFB](/claim/clm_D0C4B4DAAEFB.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 56,097,000 United States dollar | superseded | [clm_E39CFFB5B9AE](/claim/clm_E39CFFB5B9AE.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 755,827,000 United States dollar | superseded | [clm_E66B694BAD8E](/claim/clm_E66B694BAD8E.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 793,555,000 United States dollar | superseded | [clm_163565957EB5](/claim/clm_163565957EB5.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | -14,053,000 United States dollar | superseded | [clm_630CDA0D1B78](/claim/clm_630CDA0D1B78.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 55,735,000 United States dollar | superseded | [clm_9C093E7548C0](/claim/clm_9C093E7548C0.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | -4,942,000 United States dollar | superseded | [clm_9F53D28BCBE4](/claim/clm_9F53D28BCBE4.md)
- 2024-06-30 to 2024-09-30 | total_equity | 979,500,000 United States dollar | superseded | [clm_AF57F6F488BC](/claim/clm_AF57F6F488BC.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 222,213,000 United States dollar | superseded | [clm_F3E6D130A3B3](/claim/clm_F3E6D130A3B3.md)
- 2024-06-30 to 2024-09-30 | total_assets | 1,149,838,000 United States dollar | superseded | [clm_F77BD455A636](/claim/clm_F77BD455A636.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | -1,345,000 United States dollar | superseded | [clm_117F388D1551](/claim/clm_117F388D1551.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 55,769,000 United States dollar | superseded | [clm_1E141C26519C](/claim/clm_1E141C26519C.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 826,742,000 United States dollar | superseded | [clm_22A4C38E68F9](/claim/clm_22A4C38E68F9.md)
- 2024-09-30 to 2024-12-31 | total_equity | 1,014,741,000 United States dollar | superseded | [clm_2C65332EF7BD](/claim/clm_2C65332EF7BD.md)
- 2024-09-30 to 2024-12-31 | total_assets | 1,193,199,000 United States dollar | superseded | [clm_3486047ABD52](/claim/clm_3486047ABD52.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | -13,278,000 United States dollar | superseded | [clm_DA9FC301BE9A](/claim/clm_DA9FC301BE9A.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 235,094,000 United States dollar | superseded | [clm_EF220BA8C52B](/claim/clm_EF220BA8C52B.md)
- 2024-12-31 to 2025-03-31 | total_equity | 1,033,987,000 United States dollar | superseded | [clm_01C67CF88CE4](/claim/clm_01C67CF88CE4.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 238,459,000 United States dollar | superseded | [clm_16D572291F57](/claim/clm_16D572291F57.md)
- 2024-12-31 to 2025-12-31 | operating_income | -84,078,000 United States dollar | superseded | [clm_1E4A391F0366](/claim/clm_1E4A391F0366.md)
- 2024-12-31 to 2025-12-31 | net_income | -46,142,000 United States dollar | superseded | [clm_489CD0258777](/claim/clm_489CD0258777.md)
- 2024-12-31 to 2025-03-31 | total_assets | 1,273,308,000 United States dollar | superseded | [clm_76E485768D28](/claim/clm_76E485768D28.md)
- 2024-12-31 to 2025-12-31 | revenue | 937,464,000 United States dollar | superseded | [clm_C15323587F90](/claim/clm_C15323587F90.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 881,473,000 United States dollar | superseded | [clm_DC99A48A8CFE](/claim/clm_DC99A48A8CFE.md)

## 2025

- 2025-03-31 to 2025-06-30 | total_equity | 1,063,932,000 United States dollar | superseded | [clm_199198830FC4](/claim/clm_199198830FC4.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 888,432,000 United States dollar | superseded | [clm_45EC40AF9887](/claim/clm_45EC40AF9887.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | -14,089,000 United States dollar | superseded | [clm_58C3D39F1427](/claim/clm_58C3D39F1427.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 279,827,000 United States dollar | superseded | [clm_730CD46A70A3](/claim/clm_730CD46A70A3.md)
- 2025-03-31 to 2025-06-30 | total_assets | 1,347,311,000 United States dollar | superseded | [clm_789BD3E3AD70](/claim/clm_789BD3E3AD70.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 69,349,000 United States dollar | superseded | [clm_79098F20DB39](/claim/clm_79098F20DB39.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | -23,750,000 United States dollar | superseded | [clm_8180D357CEFD](/claim/clm_8180D357CEFD.md)
- 2025-06-30 to 2025-09-30 | total_assets | 1,397,882,000 United States dollar | superseded | [clm_6146B90D068A](/claim/clm_6146B90D068A.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 293,117,000 United States dollar | superseded | [clm_D43DEFDFE54E](/claim/clm_D43DEFDFE54E.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | -31,326,000 United States dollar | superseded | [clm_D5715D512004](/claim/clm_D5715D512004.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 935,516,000 United States dollar | superseded | [clm_D628559768AE](/claim/clm_D628559768AE.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | -24,281,000 United States dollar | superseded | [clm_D98A9022C1D8](/claim/clm_D98A9022C1D8.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 72,459,000 United States dollar | superseded | [clm_F2C2314BDC8E](/claim/clm_F2C2314BDC8E.md)
- 2025-06-30 to 2025-09-30 | total_equity | 1,096,752,000 United States dollar | superseded | [clm_FE4528EA813D](/claim/clm_FE4528EA813D.md)
- 2025-09-30 to 2025-12-31 | total_equity | 1,142,074,000 United States dollar | superseded | [clm_1FBEAEA1F135](/claim/clm_1FBEAEA1F135.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 72,668,000 United States dollar | superseded | [clm_388E7B4DA5CB](/claim/clm_388E7B4DA5CB.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 980,267,000 United States dollar | superseded | [clm_8910E115D11C](/claim/clm_8910E115D11C.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | -426,000 United States dollar | superseded | [clm_942729569FA1](/claim/clm_942729569FA1.md)
- 2025-09-30 to 2025-12-31 | total_assets | 1,465,060,000 United States dollar | superseded | [clm_CBE6390B8429](/claim/clm_CBE6390B8429.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | -10,836,000 United States dollar | superseded | [clm_D25AF21DB4CA](/claim/clm_D25AF21DB4CA.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 310,880,000 United States dollar | superseded | [clm_D61632BB61EC](/claim/clm_D61632BB61EC.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,064,875,000 United States dollar | superseded | [clm_0665F4FF3AFB](/claim/clm_0665F4FF3AFB.md)
- 2025-12-31 to 2026-03-31 | total_assets | 1,580,604,000 United States dollar | superseded | [clm_084FBC70D317](/claim/clm_084FBC70D317.md)
- 2025-12-31 | operating_income | -67,758,000 United States dollar | valid | [clm_29CB167F511F](/claim/clm_29CB167F511F.md)
- 2025-12-31 | revenue | 1,234,019,000 United States dollar | valid | [clm_4D1535484171](/claim/clm_4D1535484171.md)
- 2025-12-31 to 2026-03-31 | total_equity | 1,196,560,000 United States dollar | superseded | [clm_5B554F4D688D](/claim/clm_5B554F4D688D.md)
- 2025-12-31 | net_income | -31,768,000 United States dollar | valid | [clm_85E67FABB24A](/claim/clm_85E67FABB24A.md)
- 2025-12-31 | research_and_development | 291,209,000 United States dollar | valid | [clm_EF8D2E51C315](/claim/clm_EF8D2E51C315.md)

## 2026

- 2026-01-01 | ceo | Chano Fernández | valid | [clm_DA96FE1D88D1](/claim/clm_DA96FE1D88D1.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 984,590,000 United States dollar | superseded | [clm_0616E4E6C757](/claim/clm_0616E4E6C757.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 1,745,000 United States dollar | superseded | [clm_082124D10591](/claim/clm_082124D10591.md)
- 2026-03-31 to 2026-06-30 | total_assets | 1,523,617,000 United States dollar | superseded | [clm_46893D071142](/claim/clm_46893D071142.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 9,038,000 United States dollar | superseded | [clm_8F130B7F8CE4](/claim/clm_8F130B7F8CE4.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 358,005,000 United States dollar | superseded | [clm_C8D553D78340](/claim/clm_C8D553D78340.md)
- 2026-03-31 to 2026-06-30 | total_equity | 1,153,459,000 United States dollar | superseded | [clm_DAAB888DEB47](/claim/clm_DAAB888DEB47.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 80,032,000 United States dollar | superseded | [clm_DFAABE9FAC5E](/claim/clm_DFAABE9FAC5E.md)
- 2026-06-30 | quarterly_operating_income | -14,963,000 United States dollar | valid | [clm_19689DAD2A12](/claim/clm_19689DAD2A12.md)
- 2026-06-30 | quarterly_revenue | 370,576,000 United States dollar | valid | [clm_578A4469D1F0](/claim/clm_578A4469D1F0.md)
- 2026-06-30 | total_assets | 1,384,169,000 United States dollar | valid | [clm_6BAAC856A80C](/claim/clm_6BAAC856A80C.md)
- 2026-06-30 | cash_and_equivalents | 832,639,000 United States dollar | valid | [clm_7EF29FE57B32](/claim/clm_7EF29FE57B32.md)
- 2026-06-30 | total_equity | 967,024,000 United States dollar | valid | [clm_B07E3E42D067](/claim/clm_B07E3E42D067.md)
- 2026-06-30 | quarterly_research_and_development | 91,932,000 United States dollar | valid | [clm_CFBA8A613E96](/claim/clm_CFBA8A613E96.md)
- 2026-06-30 | quarterly_net_income | -8,849,000 United States dollar | valid | [clm_E5B865CC65F7](/claim/clm_E5B865CC65F7.md)
- 2026-09-01 | cfo | Erica Smith | valid | [clm_6FE0B21F18B5](/claim/clm_6FE0B21F18B5.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.